Skip to main content
Normal View

Medicinal Products

Dáil Éireann Debate, Tuesday - 27 June 2023

Tuesday, 27 June 2023

Questions (664, 665, 666, 667)

Noel Grealish

Question:

664. Deputy Noel Grealish asked the Minister for Health if he will address the unfairness in the treatment of diabetes patients in Ireland where Free Style Libre is decided on age criteria rather than clinical need; and if he will make a statement on the matter. [30812/23]

View answer

Noel Grealish

Question:

665. Deputy Noel Grealish asked the Minister for Health what plans he has in place to ensure diabetes patients have access to a glucose monitoring technology (details supplied), which has become a standard of diabetes care across Europe; and if he will make a statement on the matter. [30813/23]

View answer

Noel Grealish

Question:

666. Deputy Noel Grealish asked the Minister for Health if he recognises that remote monitoring of diabetes patients’ conditions will free up much-needed doctor and hospital appointments; and if he will make a statement on the matter. [30814/23]

View answer

Noel Grealish

Question:

667. Deputy Noel Grealish asked the Minister for Health if he is aware that the current process whereby access to a diabetes glucose monitoring technology discriminates against patients in terms of age (details supplied) and is tantamount to deprivation of access to people with a disability and needs to be addressed; and if he will make a statement on the matter. [30815/23]

View answer

Written answers

I propose to take Questions Nos. 664 to 667, inclusive, together.

The Health Service Executive (HSE) has statutory responsibility for pricing and reimbursement decisions, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. I have therefore asked the HSE to respond to the Deputy directly as soon as possible.

Question No. 665 answered with Question No. 664.
Question No. 666 answered with Question No. 664.
Question No. 667 answered with Question No. 664.
Top
Share